title: Benefits of dabigatran maintained for more than two years.
authors.forename: J
authors.initials: J
authors.lastname: Aalbers
mesh_terms: D000572:American Heart Association; D000991:Antithrombins / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply / Q000187:drug effects*; D002986:Clinical Trials as Topic; D000069604:Dabigatran; D006801:Humans; D018570:Risk Assessment; D013019:South Africa; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D014481:United States; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran